Smithers Pharmaceutical Development Services staff members have over 10 years of experience in bioanalytical analysis of biosimilars and biobetters.
Smithers Pharmaceutical Development Services staff members have over 10 years of experience in bioanalytical analysis of biosimilar development. Using multiple immunoassay platforms and bio-/cell-based assays Smithers has the scientific and regulatory expertise in bioequivalence evaluation within the most stringent timeframes. Services include PK, ADA, Nab and fit-for-purpose biomarker assays.